- Home
- PODC vs JSPR Comparison
PODC vs JSPR Comparison
Compare PODC & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PODC
- JSPR
- Stock Information
- Founded
- PODC 2013
- JSPR 2018
- Country
- PODC United States
- JSPR United States
- Employees
- PODC N/A
- JSPR N/A
- Industry
- PODC
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PODC
- JSPR Health Care
- Exchange
- PODC Nasdaq
- JSPR Nasdaq
- Market Cap
- PODC 47.8M
- JSPR 47.6M
- IPO Year
- PODC N/A
- JSPR N/A
- Fundamental
- Price
- PODC $1.65
- JSPR $2.35
- Analyst Decision
- PODC
- JSPR Buy
- Analyst Count
- PODC 0
- JSPR 11
- Target Price
- PODC N/A
- JSPR $28.00
- AVG Volume (30 Days)
- PODC 38.3K
- JSPR 442.3K
- Earning Date
- PODC 11-06-2025
- JSPR 11-06-2025
- Dividend Yield
- PODC N/A
- JSPR N/A
- EPS Growth
- PODC N/A
- JSPR N/A
- EPS
- PODC N/A
- JSPR N/A
- Revenue
- PODC $53,954,000.00
- JSPR N/A
- Revenue This Year
- PODC $17.91
- JSPR N/A
- Revenue Next Year
- PODC $14.41
- JSPR N/A
- P/E Ratio
- PODC N/A
- JSPR N/A
- Revenue Growth
- PODC 17.74
- JSPR N/A
- 52 Week Low
- PODC $1.10
- JSPR $2.22
- 52 Week High
- PODC $2.94
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- PODC 46.64
- JSPR 40.74
- Support Level
- PODC $1.51
- JSPR $2.32
- Resistance Level
- PODC $1.80
- JSPR $2.53
- Average True Range (ATR)
- PODC 0.11
- JSPR 0.16
- MACD
- PODC -0.01
- JSPR 0.03
- Stochastic Oscillator
- PODC 32.79
- JSPR 52.11
About PODC PodcastOne Inc.
PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.